Literature DB >> 11368459

Prevalence of hypertension in junior high school-aged children: effect of new recommendations in the 1996 Updated Task Force Report.

H E Adrogué1, A R Sinaiko.   

Abstract

The 1996 "Update on the 1987 Task Force Report on Blood Pressure in Children and Adolescents" adopted the fifth Korotkoff phase to define diastolic blood pressure and added height, in addition to age and gender, to develop new standards for blood pressure (BP) in children. The present study was performed to determine whether these changes altered the previously reported prevalence of hypertension in junior high school-aged children. Blood pressure screening was conducted in 19,452 fifth to eighth grade students. All students with a systolic blood pressure more than the 70th percentile had their BP measured a second time (rescreening). Using the 1996 criteria, systolic hypertension was found in 2.7% and diastolic hypertension in 2% after the screening. After the rescreening, systolic hypertension had fallen to 0.8% and diastolic hypertension to 0.4%. The prevalence of systolic hypertension was slightly higher and diastolic hypertension slightly lower than in 1987. These reports show that the overall prevalence of hypertension (1%) using the 1996 Updated Task Force criteria is similar to the prevalence using the original 1987 criteria. These results also confirm the importance of the Task Force recommendation that multiple BP measurements should be obtained before making a diagnosis of hypertension.

Entities:  

Mesh:

Year:  2001        PMID: 11368459     DOI: 10.1016/s0895-7061(00)01277-2

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  16 in total

1.  Essential hypertension in early and mid-adolescence.

Authors:  M R Savitha; B Krishnamurthy; Sudhindra Shayana R Fatthepur; A M Yashwanth Kumar; Mudassir Azeez Khan
Journal:  Indian J Pediatr       Date:  2007-11       Impact factor: 1.967

2.  Essential hypertension vs. secondary hypertension among children.

Authors:  Monesha Gupta-Malhotra; Ashish Banker; Sanjay Shete; Syed Sharukh Hashmi; John E Tyson; Michelle S Barratt; Jacqueline T Hecht; Diane M Milewicz; Eric Boerwinkle
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

Review 3.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 4.  What's new in pediatric hypertension?

Authors:  J T Flynn
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

5.  The impact of adverse childhood experiences on an urban pediatric population.

Authors:  Nadine J Burke; Julia L Hellman; Brandon G Scott; Carl F Weems; Victor G Carrion
Journal:  Child Abuse Negl       Date:  2011-06-08

Review 6.  Hypertension in young children and neonates.

Authors:  John Edward Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

Review 7.  Risk of hypertension with multicystic kidney disease: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

8.  Prehypertension and hypertension in community-based pediatric practice.

Authors:  Joan C Lo; Alan Sinaiko; Malini Chandra; Matthew F Daley; Louise C Greenspan; Emily D Parker; Elyse O Kharbanda; Karen L Margolis; Kenneth Adams; Ronald Prineas; David Magid; Patrick J O'Connor
Journal:  Pediatrics       Date:  2013-01-28       Impact factor: 7.124

Review 9.  The changing face of pediatric hypertension in the era of the childhood obesity epidemic.

Authors:  Joseph Flynn
Journal:  Pediatr Nephrol       Date:  2012-11-09       Impact factor: 3.714

10.  Impact of updated pediatric hypertension criteria on prevalence estimates of hypertension among Chinese children.

Authors:  Benmai Luo; Yizhou Lin; Si Gao; Yali Lu; Yuxin Zhao; Juan Xie; Xin Zhang; Hong Zhu
Journal:  J Hum Hypertens       Date:  2020-06-22       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.